Acta Metallurgica Sinica
Previous Articles Next Articles
Online:
Published:
通讯作者:
Abstract:
To relieve pain,reduce heavy menstrual flow and retain or enhance fertility are the dominant treatment target of adenomyosis of the uterus.Hysterectomy or adenomyomectomy remains the most important method of treatment for the disease up to now.The medical drugs in treatment of adenomyosis of the uterus are similar to those for endometriosis, with dienogest being the only specific drug at present. In this article, medical treatments for adenomyosis of the uterus on pain relief and menstrual flow reduction as well as the long-term management of patients are discussed.
Key words: adenomyosis, medical treatment, long-term management
摘要:
缓解疼痛,减少出血和促进生育是子宫腺肌病的主要治疗目标,子宫切除术或子宫病灶挖除仍然是目前主流的治疗方法。药物治疗采用的药物及用法与子宫内膜异位症治疗类似,只有地诺孕素是子宫腺肌病的专用药物。文章着重介绍子宫腺肌病缓解疼痛和减少出血的药物治疗选择及长期管理。
关键词: 子宫腺肌病, 药物治疗, 长期管理
CLC Number:
R711.71
PENG Chao,ZHOU Ying-fang. Drug choice in medical therapy and long-term management for patients with adenomyosis of the uterus.[J]. Acta Metallurgica Sinica, DOI: 10.19538/j.fk2019050108.
彭超,周应芳. 子宫腺肌病药物治疗选择及长期管理[J]. 中国实用妇科与产科杂志, DOI: 10.19538/j.fk2019050108.
0 / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgsyz.com/zgsyfck/EN/10.19538/j.fk2019050108
https://www.zgsyz.com/zgsyfck/EN/Y2019/V35/I5/516